Scarica l'app Stockscreener
1.36
3.55%
-0.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BMEA Giù?
Forum
Previsione
Biomea Fusion Inc Borsa (BMEA) Ultime notizie
Biomea Fusion Reports Positive Phase II Data For Diabetes Drug Icovamenib - Benzinga
Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026 - The Manila Times
Biomea Fusion Reports Positive 52-Week Results for Icovamenib in Type 2 Diabetes at ATTD 2026 Conference - Quiver Quantitative
Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 - GlobeNewswire
Biomea Fusion Details Diabetes, Obesity Pipeline at Citizens Conference, Sees Cash Runway to Q1 2027 - Yahoo Finance
Aug Fed Impact: Can Biomea Fusion Inc sustain its profitabilityMarket Movers & Risk Managed Investment Entry Signals - baoquankhu1.vn
Biomea Fusion, Inc. (NASDAQ:BMEA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Biomea Fusion to present icovamenib clinical data at ATTD 2006 - Traders Union
Icovamenib advances drive optimism for diabetes cure, Biomea Fusion asserts - Traders Union
Biomea Fusion (BMEA) Price Target Decreased by 10.64% to 7.14 - MSN
BMEA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Biomea Fusion, Inc. (BMEA) Presents at Oppenheimer 36th Annual Healthcare Life Sciences ConferenceSlideshow - Seeking Alpha
Aug Spikes: Can Biomea Fusion Inc ride the EV waveWeekly Profit Analysis & Real-Time Stock Entry Alerts - baoquankhu1.vn
Biomea Fusion Spotlights Durable Diabetes Data, Oral GLP-1 Weight-Loss Program at Oppenheimer Conf. - MarketBeat
BMEA: Icovamenib and BMF-650 advance in trials, targeting unmet needs in diabetes and weight loss - TradingView
Biomea Fusion : 1ST QUARTER 2026 Corporate Presentation OPCO - marketscreener.com
Biomea Fusion Updates Corporate Presentation on Metabolic Pipeline - TipRanks
Biomea Fusion posts updated investor presentation, confirms Phase II readouts and Phase I obesity data timing - TradingView
Biomea Fusion (NASDAQ: BMEA) details icovamenib and BMF-650 trial milestones - Stock Titan
Does Biomea Fusion Inc. stock trade at a discount to peersOptions Play & Momentum Based Trading Signals - mfd.ru
Biomea Fusion to Participate at Upcoming Investor Conferences - Investing News Network
Biomea Fusion advances metabolic disease science with visionary approach - Traders Union
7.85M Biomea Fusion (BMEA) shares reported in 9.9% ownership filing - Stock Titan
BMEA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Can Biomea Fusion Inc. sustain its profitabilityMarket Risk Analysis & Smart Money Movement Tracker - mfd.ru
How Biomea Fusion Inc. stock reacts to job market dataWeekly Earnings Recap & Proven Capital Preservation Methods - mfd.ru
Can Biomea Fusion Inc. ride the EV waveJuly 2025 Trade Ideas & Reliable Trade Execution Plans - mfd.ru
BMEA Should I Buy - Intellectia AI
Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Why Biomea Fusion Inc. stock appeals to analysts2025 Geopolitical Influence & Smart Swing Trading Techniques - mfd.ru
BMEA PE Ratio & Valuation, Is BMEA Overvalued - Intellectia AI
Why Biomea Fusion Inc. stock is recommended by analystsJuly 2025 WrapUp & Consistent Profit Trade Alerts - mfd.ru
Biomea Fusion (NASDAQ:BMEA) Shares Down 3%What's Next? - MarketBeat
Is Biomea Fusion Inc. stock a falling knife or bargain buy2025 Big Picture & Proven Capital Preservation Methods - mfd.ru
Biomea Fusion signals risk of beta cell overwork in diabetes - Traders Union
Biomea Fusion (BMEA) Upgraded to Buy: Here's What You Should Know - MSN
Does Biomea Fusion Inc stock benefit from AI growth2025 Momentum Check & Consistent Return Strategy Ideas - baoquankhu1.vn
Market Catalysts: Is Biomea Fusion Inc part of any major indexJuly 2025 Rallies & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Biomea Fusion, Inc.'s (NASDAQ:BMEA) largest shareholders are retail investors with 55% ownership, institutions own 38% - Yahoo Finance
Levels Update: Does Biomea Fusion Inc offer margin of safetyQuarterly Performance Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Biomea Fusion, Inc. (NASDAQ:BMEA) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Rodman & Renshaw Initiates Biomea Fusion (BMEA) at Buy with $8 Price Target - Insider Monkey
Biomea Fusion, Inc. (BMEA) Presents at 44th Annual J.P. Morgan Healthcare ConferenceSlideshow - Seeking Alpha
Biomea Fusion Spotlights Diabetes, Obesity Pipeline at JPMorgan Conference, Sets 2026 Milestones - MarketBeat
BMEA: Durable A1C reduction and advancing weight loss studies highlight strong clinical momentum - TradingView
Biomea Fusion Highlights Diabetes Pipeline at JPM Conference - TipRanks
Biomea Fusion, Inc. Updates on Icovamenib Clinical Progress - TradingView
Rodman & Renshaw Initiates Coverage on Biomea Fusion (NASDAQ:BMEA) - MarketBeat
Rodman & Renshaw initiates Biomea Fusion stock with Buy rating By Investing.com - Investing.com Nigeria
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):